The Oncosearch | Oncotarget

Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecins Editorial

Yves Pommier, Mark Cushman, James H. Doroshow

Published Dec 8, 2018 · Vol. 9, No. 99 · pp. 37286-37288

Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer Research Paper

Mariya Shapovalova, Julia Davydova, Christine Henzler, Mark Daniel, Scott M. Dehm, Christopher A. Warlick, Aaron M. LeBeau

Published Nov 30, 2018 · Vol. 9, No. 94 · pp. 36693-36704

Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma Research Paper

Piers Blombery, Ella Thompson, Georgina L. Ryland, Rachel Joyce, David J. Byrne, Christine Khoo, Stephen Lade, Mark Hertzberg, Greg Hapgood, Paula Marlton, Anand Deva, Geoffrey Lindeman, Stephen Fox, David Westerman, Miles Prince

Published Nov 16, 2018 · Vol. 9, No. 90 · pp. 36126-36136

Polymorphisms in KSHV-encoded microRNA sequences affect levels of mature viral microRNA in Kaposi Sarcoma lesions Research Paper

Vickie A. Marshall, Nazzarena Labo, Joanna Sztuba-Solinska, Elena M. Cornejo-Castro, Karen Aleman, Kathleen M. Wyvill, Lynne McNamara, Stuart F.J. Le Grice, Robert Yarchoan, Thomas S. Uldrick, Patrick MacPhail, Mark N. Polizzotto, Denise Whitby

Published Nov 9, 2018 · Vol. 9, No. 88 · pp. 35856-35869

Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition Research Paper

Douglas Spaeth-Cook, Mark Burch, Robin Belton, Bryce Demoret, Nicholas Grosenbacher, Jason David, Colin Stets, David Cohen, Reena Shakya, John L. Hays, James L. Chen

Published Nov 2, 2018 · Vol. 9, No. 86 · pp. 35676-35686

Synergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors Research Paper

Xuguang Zhu, Erik Holmsen, Sunmi Park, Mark C. Willingham, Jun Qi, Sheue-yann Cheng

Published Oct 23, 2018 · Vol. 9, No. 83 · pp. 35408-35421

Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma Research Paper

Qingyan Cui, Frank Vari, Alexandre S. Cristino, Carlos Salomon, Gregory E. Rice, Muhammed B. Sabdia, Dominic Guanzon, Carlos Palma, Marina Mathew, Dipti Talaulikar, Sanjiv Jain, Erica Han, Mark S. Hertzberg, Clare Gould, Pauline Crooks, Gayathri Thillaiyampalam, Colm Keane, Maher K. Gandhi

Published Oct 5, 2018 · Vol. 9, No. 78 · pp. 34644-34657

Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients Research Paper

Laurens E. Franssen, Inger S. Nijhof, Chad C. Bjorklund, Hsiling Chiu, Ruud Doorn, Jeroen van Velzen, Maarten Emmelot, Berris van Kessel, Mark-David Levin, Gerard M.J. Bos, Annemiek Broijl, Saskia K. Klein, Harry R. Koene, Andries C. Bloem, Aart Beeker, Laura M. Faber, Ellen van der Spek, Reinier Raymakers, Pieter Sonneveld, Sonja Zweegman, Henk M. Lokhorst, Anjan Thakurta, Xiaozhong Qian, Tuna Mutis, Niels W.C.J. van de Donk

Published Sep 21, 2018 · Vol. 9, No. 74 · pp. 34009-34021

Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3 Priority Research Paper

Kozo Nagai, Lihong Hou, Li Li, Bao Nguyen, Tessa Seale, Courtney Shirley, Hayley Ma, Mark Levis, Gabriel Ghiaur, Amy Duffield, Donald Small

Published Aug 31, 2018 · Vol. 9, No. 68 · pp. 32885-32899

RNA based individualized drug selection in breast cancer patients without patient-matched normal tissue Research Paper

Michael Forster, Adam Mark, Friederike Egberts, Elisa Rosati, Elke Rodriguez, Martin Stanulla, Dirk Bauerschlag, Christian Schem, Nicolai Maass, Anu Amallraja, Karla K. Murphy, Bruce R. Prouse, Raed A. Sulaiman, Brandon M. Young, Micaela Mathiak, Georg Hemmrich-Stanisak, David Ellinghaus, Stephan Weidinger, Philip Rosenstiel, Norbert Arnold, Brian Leyland-Jones, Casey B. Williams, Andre Franke, Tobias MeiÃŸner

Published Aug 17, 2018 · Vol. 9, No. 64 · pp. 32362-32372

A diagnostic autoantibody signature for primary cutaneous melanoma Research Paper

Pauline Zaenker, Johnny Lo, Robert Pearce, Phillip Cantwell, Lester Cowell, Mark Lee, Christopher Quirk, Henry Law, Elin Gray, Mel Ziman

Published Jul 17, 2018 · Vol. 9, No. 55 · pp. 30539-30551

Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice Correction

Patrick M. Reeves, Mojgan A. Abbaslou, Farah R.W. Kools, Kritchai Vutipongsatorn, Xiaoyun Tong, Christina Gavegnano, Raymond F. Schinazi, Mark C. Poznansky

Published Jul 13, 2018 · Vol. 9, No. 54 · pp. 30472-30472

An evaluation in vitro of the efficacy of nutlin-3 and topotecan in combination with ¹⁷⁷Lu-DOTATATE for the treatment of neuroblastoma Research Paper

Mathias Tesson, Richa Vasan, Andreas Hock, Colin Nixon, Colin Rae, Mark Gaze, Robert Mairs

Published Jun 26, 2018 · Vol. 9, No. 49 · pp. 29082-29096

Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT) Research Paper

Connie H.M. Ho, Chi-Leung Chiang, Francis A.S. Lee, Horace C.W. Choi, Jeffery C.H. Chan, Cynthia S.Y. Yeung, J.J. Huang, Mark K.H. Chan, Oliver Blanck, Frank C.S. Wong

Published Jun 22, 2018 · Vol. 9, No. 48 · pp. 28818-28829

RIOK1 kinase activity is required for cell survival irrespective of MTAP status Research Paper

Alexandra HÃ¶rmann, Barbara Hopfgartner, Thomas KÃ¶cher, Maja Corcokovic, Teresa Krammer, Christoph Reiser, Gerd Bader, Junwei Shi, Katharina EhrenhÃ¶fer, Simon WÃ¶hrle, Norbert Schweifer, Christopher R. Vakoc, Norbert Kraut, Mark Pearson, Mark Petronczki, Ralph A. NeumÃ¼ller

Published Jun 19, 2018 · Vol. 9, No. 47 · pp. 28625-28637

Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients Clinical Research Papers

Sebastian Regnery, Sebastian Adeberg, Constantin Dreher, Johanna Oberhollenzer, Jan-Eric Meissner, Steffen Goerke, Johannes Windschuh, Katerina Deike-Hofmann, Sebastian Bickelhaupt, Moritz Zaiss, Alexander Radbruch, Martin Bendszus, Wolfgang Wick, Andreas Unterberg, Stefan Rieken, JÃ¼rgen Debus, Peter Bachert, Mark Ladd, Heinz-Peter Schlemmer, Daniel Paech

Published Jun 19, 2018 · Vol. 9, No. 47 · pp. 28772-28783

Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review Review

Young Kwang Chae, Lauren Chiec, Scott K. Adney, Josh Waitzman, Ricardo Costa, Benedito Carneiro, Maria Matsangou, Mark Agulnik, Peter Kopp, Frank Giles

Published Jun 15, 2018 · Vol. 9, No. 46 · pp. 28281-28289

New susceptibility loci for cutaneous melanoma risk and progression revealed using a porcine model Research Paper

Emmanuelle Bourneuf, Jordi EstellÃ©, Amandine Blin, FranÃ§oise CrÃ©chet, Maria del Pilar Schneider, HÃ©lÃ¨ne Gilbert, Myriam Brossard, Amaury Vaysse, Mark Lathrop, Silvia Vincent-Naulleau, Florence Demenais

Published Jun 12, 2018 · Vol. 9, No. 45 · pp. 27682-27697

The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer Research Paper

Jonathan P. Evans, Boleslaw K. Winiarski, Paul A. Sutton, Robert P. Jones, Lorenzo Ressel, Carrie A. Duckworth, Mark D. Pritchard, Zhi-Xiu Lin, Vicky L. Fretwell, Elizabeth M. Tweedle, Eithne Costello, Christopher E. Goldring, Ian M. Copple, Kevin B. Park, Daniel H. Palmer, Neil R. Kitteringham

Published Jun 5, 2018 · Vol. 9, No. 43 · pp. 27104-27116

The dynamics of HER2 status in esophageal adenocarcinoma Research Paper

Aafke Creemers, Eva A. Ebbing, Gerrit K.J. Hooijer, Lisanne Stap, Rajni A. Jibodh-Mulder, Susanne S. Gisbertz, Mark I. van Berge Henegouwen, Maurits L. van Montfoort, Maarten C.C.M. Hulshof, Kausilia K. Krishnadath, Martijn G.H. van Oijen, Maarten F. Bijlsma, Sybren L. Meijer, Hanneke W.M. van Laarhoven

Published Jun 1, 2018 · Vol. 9, No. 42 · pp. 26787-26799

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecins Editorial

Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer Research Paper

Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma Research Paper

Polymorphisms in KSHV-encoded microRNA sequences affect levels of mature viral microRNA in Kaposi Sarcoma lesions Research Paper

Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition Research Paper

Synergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors Research Paper

Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma Research Paper

Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients Research Paper

Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3 Priority Research Paper

RNA based individualized drug selection in breast cancer patients without patient-matched normal tissue Research Paper

A diagnostic autoantibody signature for primary cutaneous melanoma Research Paper

Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice Correction

An evaluation in vitro of the efficacy of nutlin-3 and topotecan in combination with ¹⁷⁷Lu-DOTATATE for the treatment of neuroblastoma Research Paper

Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT) Research Paper

RIOK1 kinase activity is required for cell survival irrespective of MTAP status Research Paper

Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients Clinical Research Papers

Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review Review

New susceptibility loci for cutaneous melanoma risk and progression revealed using a porcine model Research Paper

The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer Research Paper

The dynamics of HER2 status in esophageal adenocarcinoma Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecins Editorial

Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer Research Paper

Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma Research Paper

Polymorphisms in KSHV-encoded microRNA sequences affect levels of mature viral microRNA in Kaposi Sarcoma lesions Research Paper

Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition Research Paper

Synergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors Research Paper

Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma Research Paper

Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients Research Paper

Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3 Priority Research Paper

RNA based individualized drug selection in breast cancer patients without patient-matched normal tissue Research Paper

A diagnostic autoantibody signature for primary cutaneous melanoma Research Paper

Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice Correction

An evaluation in vitro of the efficacy of nutlin-3 and topotecan in combination with 177Lu-DOTATATE for the treatment of neuroblastoma Research Paper

Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT) Research Paper

RIOK1 kinase activity is required for cell survival irrespective of MTAP status Research Paper

Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients Clinical Research Papers

Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review Review

New susceptibility loci for cutaneous melanoma risk and progression revealed using a porcine model Research Paper

The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer Research Paper

The dynamics of HER2 status in esophageal adenocarcinoma Research Paper

An evaluation in vitro of the efficacy of nutlin-3 and topotecan in combination with ¹⁷⁷Lu-DOTATATE for the treatment of neuroblastoma Research Paper